1.14
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.14 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.11 | 1.09 | 1.16 | 1.13 | 1.14 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.12 | 1.19 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 888 | 514,331 | $ 1.13 | $ 579,692 | 895,354 | 0.415 - 1.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:10 | formt | 800 | $ 1.14 | USD |
Citius Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 63.36M | 55.58M | 43.24M | $ - | $ - | -0.46 | -2.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 22.10% |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.10 | 1.19 | 1.05 | 1.11 | 731,449 | 0.04 | 3.64% |
| 1 Month | 1.09 | 1.19 | 0.970101 | 1.09 | 623,663 | 0.05 | 4.59% |
| 3 Months | 1.11 | 1.27 | 0.8729 | 1.08 | 659,782 | 0.03 | 2.7% |
| 6 Months | 1.20 | 1.77 | 0.78 | 1.14 | 995,895 | -0.06 | -5.0% |
| 1 Year | 0.9798 | 1.97 | 0.415 | 1.12 | 1,439,902 | 0.1602 | 16.35% |
| 3 Years | 4.10 | 4.60 | 0.40 | 1.14 | 591,098 | -2.96 | -72.2% |
| 5 Years | 3.40 | 5.49 | 0.40 | 1.20 | 525,743 | -2.26 | -66.47% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments. |
